Related references
Note: Only part of the references are listed.International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
Franck Pages et al.
LANCET (2018)
CD4+ T cell help in cancer immunology and immunotherapy
Jannie Borst et al.
NATURE REVIEWS IMMUNOLOGY (2018)
TH9 cells in anti-tumor immunity
Thaiz Rivera Vargas et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
Michael J. Overman et al.
LANCET ONCOLOGY (2017)
Systemic Immunity Is Required for Effective Cancer Immunotherapy
Matthew H. Spitzer et al.
CELL (2017)
Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
Christina Pfirschke et al.
IMMUNITY (2016)
Heparan Sulfate Proteoglycans Promote Telomerase Internalization and MHC Class II Presentation on Dendritic Cells
Jeanne Galaine et al.
JOURNAL OF IMMUNOLOGY (2016)
Immunoprevalence and magnitude of HLA-DP4 versus HLA-DR-restricted spontaneous CD4+ Th1 responses against telomerase in cancer patients
Caroline Laheurte et al.
ONCOIMMUNOLOGY (2016)
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
Lorenzo Galluzzi et al.
CANCER CELL (2015)
Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes
Sinu Paul et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2015)
Tapping CD4 T Cells for Cancer Immunotherapy: The Choice of Personalized Genomics
Maurizio Zanetti
JOURNAL OF IMMUNOLOGY (2015)
Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance
Eva Martinez-Balibrea et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Successful treatment of conversion chemotherapy for initially unresectable synchronous colorectal liver metastasis
Kenta Baba et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
High-throughput monitoring of human tumor-specific T-cell responses with large peptide pools
Mathieu F. Chevalier et al.
ONCOIMMUNOLOGY (2015)
Emerging cytokine networks in colorectal cancer
Nathan R. West et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Molecular Pathways: The Immunogenic Effects of Platinum-Based Chemotherapeutics
Stanleyson V. Hato et al.
CLINICAL CANCER RESEARCH (2014)
Identification of MAGEA antigens as causal players in the development of tamoxifen-resistant breast cancer
P-P Wong et al.
ONCOGENE (2014)
Overexpression of goosecoid homeobox is associated with chemoresistance and poor prognosis in ovarian carcinoma
Kyong-Won Kang et al.
ONCOLOGY REPORTS (2014)
Expansion of Anti-Mesothelin Specific CD4+ and CD8+ T Cell Responses in Patients with Pancreatic Carcinoma
Yuan Chen et al.
PLOS ONE (2014)
Colorectal cancer: From prevention to personalized medicine
Gemma Binefa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Histopathologic factors affecting tumor recurrence after hepatic resection in colorectal liver metastases
Min-Su Park et al.
ANNALS OF SURGICAL TREATMENT AND RESEARCH (2014)
Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
Laurence Zitvogel et al.
IMMUNITY (2013)
Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor
Magalie Dosset et al.
CLINICAL CANCER RESEARCH (2012)
Analysis of Spontaneous Tumor-Specific CD4 T-cell Immunity in Lung Cancer Using Promiscuous HLA-DR Telomerase-Derived Epitopes: Potential Synergistic Effect with Chemotherapy Response
Yann Godet et al.
CLINICAL CANCER RESEARCH (2012)
MELOE-1 Antigen Contains Multiple HLA Class II T Cell Epitopes Recognized by Th1 CD4+T Cells from Melanoma Patients
Mathilde Bobinet et al.
PLOS ONE (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer
Marie Tosolini et al.
CANCER RESEARCH (2011)
Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice
W. Joost Lesterhuis et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Peptide binding predictions for HLA DR, DP and DQ molecules
Peng Wang et al.
BMC BIOINFORMATICS (2010)
Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses
W. M. Liu et al.
BRITISH JOURNAL OF CANCER (2010)
A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients
W. J. Lesterhuis et al.
BRITISH JOURNAL OF CANCER (2010)
5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
Julie Vincent et al.
CANCER RESEARCH (2010)
The Cancer/Testis Antigen CAGE with Oncogenic Potential Stimulates Cell Proliferation by Up-regulating Cyclins D1 and E in an AP-1-and E2F-dependent Manner
Elaine Por et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice
Rupal Ramakrishnan et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma
W-F Cheng et al.
BRITISH JOURNAL OF CANCER (2009)
Deficient mismatch repair system in patients with sporadic advanced colorectal cancer
M. Koopman et al.
BRITISH JOURNAL OF CANCER (2009)
Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
Thierry Andre et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Induction of Both CD8+ and CD4+ T-Cell - Mediated Responses in Colorectal Cancer Patients by Colon Antigen-1
Cristina Maccalli et al.
CLINICAL CANCER RESEARCH (2008)
Multiple roles for CD4(+) T cells in anti-tumor immune responses
Richard Kennedy et al.
IMMUNOLOGICAL REVIEWS (2008)
Combined effects of 5-Fluorouracil, Folinic acid and Oxaliplatin on the expression of carcinoembryonic antigen in human colon cancer cells: pharmacological basis to develop an active antitumor immunochemotherapy
Salvatore P. Prete et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2008)
A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach
Peng Wang et al.
PLOS COMPUTATIONAL BIOLOGY (2008)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
Calreticulin exposure dictates the immunogenicity of cancer cell death
Michel Obeid et al.
NATURE MEDICINE (2007)
Identification and immunotherapeutic targeting of antigens induced by chemotherapy
B Rubinfeld et al.
NATURE BIOTECHNOLOGY (2006)
A novel time-course cDNA microarray analysis method identifies genes associated with the development of cisplatin resistance
MA Whiteside et al.
ONCOGENE (2004)
Treatment of human colon carcinoma cell lines with anti-neoplastic agents enhances their lytic sensitivity to antigen-specific CD8+ cytotoxic T lymphocytes
ES Bergmann-Leitner et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2001)
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
A de Gramont et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
